未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏In Vitro and In Vivo Activity of Cabozantinib (XL184), an Inhibitor of RET, MET, and VEGFR2, in a Model of Medullary Thyroid Cancer
Bentzien, Frauke; Zuzow, Marcus; Heald, Nathan; Gibson, Anna; Shi, Yongchang; Goon, Leanne; Yu, Peiwen; Engst, Stefan; Zhang, Wentao; Huang, Donghui; Zhao, Lora; Vysotskaia, Valentina; Chu, Felix; Bautista, Rajana; Cancilla, Belinda; Lamb, Peter; Joly, Alison H.; Yakes, F. Michael
分享
收藏